HomeChina

China

Qi Biodesign Completes $75M in Total Funding

Qi Biodesign, a Beijing, China-based biotechnology company pioneering next-generation genome editing technologies, completed its Series A funding round. The Series A round was led...

Allink Biotherapeutics Raises $42M in Series A Financing

Allink Biotherapeutics, a Beijing, China-based clinical-stage biotechnology company providing new bispecific antibody and antibody-drug conjugate (ADC) therapeutics, raised $42M in Series A funding. The round...

C Ray Therapeutics Completes Over $100M Series A+ Financing

C Ray Therapeutics, a Chengdu, China-based enterprise in the field of radiopharmaceuticals, raised over $100M in Series A+ funding. The round was led by Shenzhen...

DeepRoute.ai Raises Major Series C1 Funding

DeepRoute.ai, Shenzhen, a China-based artificial intelligence company specializing in developing smart driving solutions, raised $100M in Series C1 funding. The round was led by OEM. The...

TenNor Raises Over RMB300M Financing

TenNor Therapeutics, a Suzhou, China-based clinical stage company dedicated to developing new therapies for infectious diseases, raised over RMB300M in Series E funding. Backers included...

LongBio Closes Series B2 Financing

LongBio, a Shanghai, China-based Phase III-stage biotech company focused on the R&D of antibody and fusion protein drugs for allergies and complement-mediated diseases, raised...

Ex-Co-Founder of Hamster Kombat Unleashes New Game-Changing Hard Fork: Meet Hamster Cash

Beijing, China, 23rd September 2024, Chainwire

LTZ Therapeutics Raises Over $20M in Series A Financing

LTZ Therapeutics, a Redwood City, CA- and Shenzen, China-based immunotherapy-focused biotech company, closed its Series A financing of over $20m. This round, which brought...

Synthetica Pioneering Closes Series A Funding Round

Shenzhen Synthetica Pioneering Co., Ltd., a Shenzen, China-based biotech startup specializing in synthetic biology for engineering novel living bacterial therapeutics, closed a Series A funding...

Rona Therapeutics Raises $35M Series A+ Financing

Rona Therapeutics, a Shanghai, China-based clinical stage platform company which specializes in nucleic acid drug research and development, raised $35M in Series A+ funding. The...

AusperBio Raises $37M in Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company with operations in the USA and China, closed a $37m Series A financing round. The round...

Ronovo Surgical Closes $44M Series B Financing to Advance CARINA™ Platform Towards Commercialization and International Expansion

SHANGHAI and ORLANDO, June 20, 2024 – Ronovo Surgical, a Shanghai-based medical technology innovator developing novel surgical robotics for soft tissue procedures, announces the...

THE DAILY NEWSLETTER - SIGNUP